Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Suzanne Ii

BA (Cum Laude), MA, MSc, PhD


Qualitative Researcher

  • SocialCareTalk Formative Evaluation Project

Research Areas


Dr Suzanne Ii is a Qualitative Researcher in the Medical Sociology & Health Experiences Research Group. She is the lead researcher on the SocialCareTalk project where she is conducting a formative evaluation of the SocialCareTalk online platform to explore the needs of multiple stakeholder groups to identify gaps, and streamline the platform in its content and functioning to meet the indicated needs within social care.

Her previous work as a Mixed Methods Researcher explored patient engagement in the medicines lifecycle to identify gaps and create tools to improve the patient engagement landscape using mixed methods. She also worked on the formative assessment and research study to understand boundary spanning in translational medical research. Suzanne also completed a study that explored the perceptions of tri-sectoral collaborations between academia, healthcare and industry to understand the barriers and facilitators to medical innovation adoption in the NHS.

Suzanne holds a BA in Anthropology, specialising in Physical Anthropology with a minor in Japanese from California State University, Fresno.  She holds a MA degree in East Asian Studies from Stanford University.  Suzanne also holds a MSc degree in Visual Anthropology from the University of Oxford.  She completed her doctoral studies at the Institute of Psychiatry, Psychology and Neuroscience's National Addiction Centre, King's College London, earning her a PhD in Addiction Sciences.  She used quantitative and qualitative research methods and an applied theoretical framework to explore the dietary and nutrient intake, dietary behaviours and physical changes that occurred in people receiving opioid agonist treatment therapy.